4-[2-(2,4-difluoroanilino)-2-oxoethyl]-N-[4-fluoro-3-(trifluoromethyl)phenyl]-1,4-diazepane-1-carboxamide
C21H20F6N4O2 — CID 3861882
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[2-(2,4-difluoroanilino)-2-oxoethyl]-N-[4-fluoro-3-(trifluoromethyl)phenyl]-1,4-diazepane-1-carboxamide
4-[2-(2,4-difluoroanilino)-2-oxoethyl]-N-[4-fluoro-3-(trifluoromethyl)phenyl]-1,4-diazepane-1-carboxamide (PubChem CID 3861882) has the molecular formula C21H20F6N4O2 and a molecular weight of 474.41 g/mol. Its IUPAC name is 4-[2-(2,4-difluoroanilino)-2-oxoethyl]-N-[4-fluoro-3-(trifluoromethyl)phenyl]-1,4-diazepane-1-carboxamide.
Molecular Properties
| Compound Name | 4-[2-(2,4-difluoroanilino)-2-oxoethyl]-N-[4-fluoro-3-(trifluoromethyl)phenyl]-1,4-diazepane-1-carboxamide |
|---|---|
| PubChem CID | 3861882 |
| Molecular Formula | C21H20F6N4O2 |
| Molecular Weight | 474.41 g/mol |
| Exact Mass | 474.15 |
| IUPAC Name | 4-[2-(2,4-difluoroanilino)-2-oxoethyl]-N-[4-fluoro-3-(trifluoromethyl)phenyl]-1,4-diazepane-1-carboxamide |
| SMILES | O=C(CN1CCCN(C(=O)Nc2ccc(F)c(C(F)(F)F)c2)CC1)Nc1ccc(F)cc1F |
| InChI | InChI=1S/C21H20F6N4O2/c22-13-2-5-18(17(24)10-13)29-19(32)12-30-6-1-7-31(9-8-30)20(33)28-14-3-4-16(23)15(11-14)21(25,26)27/h2-5,10-11H,1,6-9,12H2,(H,28,33)(H,29,32) |
| InChIKey | ABHJGUXTRDIAHO-UHFFFAOYSA-N |
| XLogP | 4.30 |
| TPSA | 64.68 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 474.41 |
| LogP ≤ 5 | 4.30 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 3861882 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.